Compare TOMZ & BFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TOMZ | BFRI |
|---|---|---|
| Founded | 1979 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Diversified Commercial Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.9M | 12.2M |
| IPO Year | 2009 | 2021 |
| Metric | TOMZ | BFRI |
|---|---|---|
| Price | $1.91 | $0.86 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | 25.2K | ★ 222.3K |
| Earning Date | 11-13-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 13.64 | ★ 67.70 |
| EPS | ★ N/A | N/A |
| Revenue | $5,635,927.00 | ★ $41,705,000.00 |
| Revenue This Year | $111.80 | $10.65 |
| Revenue Next Year | $52.23 | $15.88 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 11.75 |
| 52 Week Low | $1.21 | $0.57 |
| 52 Week High | $9.73 | $1.66 |
| Indicator | TOMZ | BFRI |
|---|---|---|
| Relative Strength Index (RSI) | 68.25 | 41.99 |
| Support Level | $1.28 | $0.85 |
| Resistance Level | $1.95 | $0.97 |
| Average True Range (ATR) | 0.20 | 0.06 |
| MACD | 0.04 | 0.02 |
| Stochastic Oscillator | 80.24 | 51.74 |
TOMI Environmental Solutions Inc is a leader in bacteria decontamination and infectious disease control, offering environmentally friendly solutions for indoor air and surface disinfection and decontamination. Its flagship product, SteraMist, uses patented and registered Binary Ionization Technology (BIT) to deliver a low-percentage hydrogen peroxide-based fog or mist to affect all indoor environments and surface areas. The product portfolio of the company includes The SteraPak, The Surface Unit, SteraMist Transport, The NV+, The Environment System, and others.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions. The company's revenues are derived from within the United States and, therefore, no other geographical segments.